Literature DB >> 22578855

Medical malpractice and hernia repair: an analysis of case law.

Amanda L Walters1, Kristian T Dacey, Alla Y Zemlyak, Amy E Lincourt, B Todd Heniford.   

Abstract

BACKGROUND: Litigation analysis and clinician education are essential to reduce the number and cost of malpractice claims. This study evaluates the clinical characteristics and legal outcomes of medical malpractice litigation initiated by patients having undergone a hernia repair operation.
MATERIALS AND METHODS: Published civil suits were obtained from a legal database for state and federal decisions constituting case law. The published material includes information on defendants, plaintiffs, allegations, outcomes, and a variety of legal issues. A retrospective review of 44 published cases from 25 states was performed.
RESULTS: Complications were present in 20 of 44 (45%) suits, four (9%) of which were because of infection. Death occurred in five (11%) cases, and failure to obtain informed consent was alleged in seven (16%) of the suits. Retained foreign bodies were present in 7 of the 44 (16%) suits. Other allegations included incorrect surgical technique, insufficient need for surgery, and emotional distress. Most (64%) patients initiating malpractice litigation were male, and inguinal, hiatal, and ventral hernia repairs account for 39%, 27%, and 14% of cases, respectively. Most suits (40%) were initiated in Southern states. Surgical mesh was indicated in 5 of 44 (11%) suits but four of five were unrelated to the suit. One patient initiated litigation because of the fact that the surgeon did not use mesh during surgery, which was discussed preoperatively during the informed consent. The court ruled in favor of the plaintiff in 12 of 44 (27%) suits, with compensation ranging from roughly $19,000 to $8,000,000. Louisiana and New York had six and seven suits each, which appears disproportionate given their respective populations.
CONCLUSION: Complications and death resulting from alleged clinical negligence play a significant role in both the initiation and the outcome of malpractice litigation. Retained foreign bodies and lack of informed consent account for roughly one-third of malpractice litigation associated with hernia repairs. Many of these suits may be avoided with proper patient education and documentation of such along with standard operative preventative measures.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22578855     DOI: 10.1016/j.jss.2012.04.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Traditional native tissue vs mesh-augmented pelvic organ prolapse repairs: providing an accurate interpretation of current literature. Comment.

Authors:  B Jacquetin
Journal:  Int Urogynecol J       Date:  2013-01       Impact factor: 2.894

2.  Esophageal perforation and rupture: a comprehensive medicolegal examination of 59 jury verdicts and settlements.

Authors:  Peter F Svider; Anna A Pashkova; Gian-Paul Vidal; Andrew C Mauro; Jean Anderson Eloy; Ravi J Chokshi
Journal:  J Gastrointest Surg       Date:  2013-10       Impact factor: 3.452

3.  Factors influencing inguinal hernia symptoms and preoperative evaluation of symptoms by patients: results of a prospective study including 1647 patients.

Authors:  K Mitura; M Śmietański; S Kozieł; K Garnysz; I Michałek
Journal:  Hernia       Date:  2018-04-26       Impact factor: 4.739

4.  Analysis of Factors Associated With Rhytidectomy Malpractice Litigation Cases.

Authors:  Aron Kandinov; Sean Mutchnick; Vaibhuv Nangia; Peter F Svider; Giancarlo F Zuliani; Mahdi A Shkoukani; Michael A Carron
Journal:  JAMA Facial Plast Surg       Date:  2017-07-01       Impact factor: 4.611

5.  The change in groin pain perception after transabdominal preperitoneal inguinal hernia repair with glue fixation: a prospective trial of a single surgeon's experience.

Authors:  Kryspin Mitura; Karolina Garnysz; Dorota Wyrzykowska; Irmina Michałek
Journal:  Surg Endosc       Date:  2018-03-30       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.